184 related articles for article (PubMed ID: 12879264)
1. Soluble HLA-I (s-HLA-I) synthesis in systemic lupus erythematosus.
Adamashvili I; Wolf R; Aultman D; Milford EL; Jaffe S; Hall V; Pressly T; Minagar A; Kelley R
Rheumatol Int; 2003 Nov; 23(6):294-300. PubMed ID: 12879264
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of serum soluble HLA class I antigens in systemic lupus erythematosus.
Hagihara M; Shimura T; Yamamoto K; Sujirachato K; Tsuji S; Yamamura M; Tsuji K
Tokai J Exp Clin Med; 1993 Jun; 18(1-2):61-4. PubMed ID: 7940609
[TBL] [Abstract][Full Text] [Related]
3. Soluble HLA in saliva of patients with autoimmune rheumatic diseases.
Adamashvili I; Pressly T; Gebel H; Milford E; Wolf R; Mancini M; Sittg K; Ghali GE; Hall V; McDonald JC
Rheumatol Int; 2002 Jun; 22(2):71-6. PubMed ID: 12070679
[TBL] [Abstract][Full Text] [Related]
4. Soluble HLA class I antigens in patients with type I diabetes and their family members.
Adamashvili I; McVie R; Gelder F; Gautreaux M; Jaramillo J; Roggero T; McDonald J
Hum Immunol; 1997 Jul; 55(2):176-83. PubMed ID: 9361970
[TBL] [Abstract][Full Text] [Related]
5. Increased level of soluble HLA class I antigens in systemic lupus erythematosus: correlation with anti-DNA antibodies and leukopenia.
Kippner L; Klint C; Sturfelt G; Bengtsson AA; Eriksson H; Truedsson L
J Autoimmun; 2001 Jun; 16(4):471-8. PubMed ID: 11437496
[TBL] [Abstract][Full Text] [Related]
6. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus.
Rizzo R; Hviid TV; Govoni M; Padovan M; Rubini M; Melchiorri L; Stignani M; Carturan S; Grappa MT; Fotinidi M; Ferretti S; Voss A; Laustrup H; Junker P; Trotta F; Baricordi OR
Tissue Antigens; 2008 Jun; 71(6):520-9. PubMed ID: 18380776
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum level of soluble HLA class I antigens in patients with systemic lupus erythematosus.
Tsuchiya N; Shiota M; Yamaguchi A; Ito K
Arthritis Rheum; 1996 May; 39(5):792-6. PubMed ID: 8639176
[TBL] [Abstract][Full Text] [Related]
8. Increased level of serum HLA class I antigens in patients with systemic lupus in patients with systemic lupus erythematosus. Correlation with disease activity.
Bresciani A; Pirozzi G; Spera M; Lombardi ML; Ambrosone L; Migliaresi S; Ferrone S; Manzo C
Tissue Antigens; 1998 Jul; 52(1):44-50. PubMed ID: 9714473
[TBL] [Abstract][Full Text] [Related]
9. Expression of human leukocyte antigen-G in systemic lupus erythematosus.
Rosado S; Perez-Chacon G; Mellor-Pita S; Sanchez-Vegazo I; Bellas-Menendez C; Citores MJ; Losada-Fernandez I; Martin-Donaire T; Rebolleda N; Perez-Aciego P
Hum Immunol; 2008 Jan; 69(1):9-15. PubMed ID: 18295670
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells upregulate Treg cells via sHLA-G in SLE patients.
Chen C; Liang J; Yao G; Chen H; Shi B; Zhang Z; Zhao C; Zhang H; Sun L
Int Immunopharmacol; 2017 Mar; 44():234-241. PubMed ID: 28129605
[TBL] [Abstract][Full Text] [Related]
11. Value of HLA-DR genotype in systemic lupus erythematosus and lupus nephritis: a meta-analysis.
Niu Z; Zhang P; Tong Y
Int J Rheum Dis; 2015 Jan; 18(1):17-28. PubMed ID: 25546242
[TBL] [Abstract][Full Text] [Related]
12. Synchronous decline of serum-soluble HLA class I antigen and beta-cell function in insulin-dependent diabetes mellitus.
Nakanishi K; Kobayashi T; Komatsu Y; Kogawa N; Hagihara M; Tsuji K
Clin Immunol Immunopathol; 1997 Dec; 85(3):246-52. PubMed ID: 9400624
[TBL] [Abstract][Full Text] [Related]
13. Detection of soluble HLA-G molecules in plasma and amniotic fluid.
Rebmann V; Pfeiffer K; Pässler M; Ferrone S; Maier S; Weiss E; Grosse-Wilde H
Tissue Antigens; 1999 Jan; 53(1):14-22. PubMed ID: 10082427
[TBL] [Abstract][Full Text] [Related]
14. Histological antiphospholipid-associated nephropathy versus lupus nephritis in patients with systemic lupus erythematosus: an observational cross-sectional study with longitudinal follow-up.
Gerhardsson J; Sundelin B; Zickert A; Padyukov L; Svenungsson E; Gunnarsson I
Arthritis Res Ther; 2015 Apr; 17(1):109. PubMed ID: 25927214
[TBL] [Abstract][Full Text] [Related]
15. Soluble HLA-I in rheumatic diseases.
Wolf RE; Adamashvili IM; Gelder FB; Hall VC; Fraser PA; McDonald JC
Hum Immunol; 1998 Oct; 59(10):644-9. PubMed ID: 9757946
[TBL] [Abstract][Full Text] [Related]
16. HLA-A23/HLA-A24 serotypes and dementia interaction in the elderly: Association with increased soluble HLA class I molecules in plasma.
Cardoso EM; Lourenço-Gomes V; Esgalhado AJ; Reste-Ferreira D; Oliveira N; Amaral AS; Martinho A; Gama JMR; Verde I; Lourenço O; Fonseca AM; Buchli R; Arosa FA
HLA; 2023 Dec; 102(6):660-670. PubMed ID: 37400938
[TBL] [Abstract][Full Text] [Related]
17. Relationship of anticardiolipin antibodies and antiphospholipid syndrome to HLA-DR7 in Mexican patients with systemic lupus erythematosus (SLE).
Granados J; Vargas-Alarcón G; Drenkard C; Andrade F; Melín-Aldana H; Alcocer-Varela J; Alarcón-Segovia D
Lupus; 1997; 6(1):57-62. PubMed ID: 9116720
[TBL] [Abstract][Full Text] [Related]
18. Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus.
Gambelunghe G; Gerli R; Bocci EB; Del Sindaco P; Ghaderi M; Sanjeevi CB; Bistoni O; Bini V; Falorni A
Rheumatology (Oxford); 2005 Mar; 44(3):287-92. PubMed ID: 15522921
[TBL] [Abstract][Full Text] [Related]
19. Soluble HLA-II expression in African-Americans.
Adamashvili I; Fraser PA; Milford EL; Sittig K; Gebel H; Zibari G; Pressly T; McDonald JC
Inflamm Res; 2002 Jun; 51(6):290-4. PubMed ID: 12088269
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of HLA-DRB1 allelic associations with systemic lupus erythematous and lupus nephritis in Taiwan.
Pan CF; Wu CJ; Chen HH; Dang CW; Chang FM; Liu HF; Chu CC; Lin M; Lee YJ
Lupus; 2009 Jul; 18(8):698-704. PubMed ID: 19502265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
